Patent intelligence · US
US 8304439
Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage
Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage
Patent details — US 8304439
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 6, 2012
- Expiration
- Nov 1, 2032
- Applicant
- POLITECHNIKA LÓDZKA
- Claims
- 19
- CPC classes
- A61K, A61K31/4425
Quick answer
US 8304439 (Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage) is held by POLITECHNIKA LÓDZKA. Status: granted. Granted Nov 6, 2012. Expires Nov 1, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- POLITECHNIKA LÓDZKA
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K31/4425
More from POLITECHNIKA LÓDZKA
Related pharmaceutical patents in our USPTO index.
-
US 12415779
Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof
granted -
US 12391642
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12331026
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors
granted -
US 12264167
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
granted -
US 12171741
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12077506
Indane derivatives as hypoxia inducible factor-2(α) inhibitors
granted -
US 11939303
Sulfamate derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, their medical use and the method of obtaining 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamate derivatives
granted -
US 11753366
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted
Frequently asked questions
What is US patent 8304439?
US 8304439 (Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage) is held by POLITECHNIKA LÓDZKA. Status: granted. Granted Nov 6, 2012. Expires Nov 1, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8304439?
POLITECHNIKA LÓDZKA is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 69 pharmaceutical patents for this assignee.
When does US 8304439 expire?
Our index shows an expiration date of Nov 1, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.